Please enable JavaScript in your web browser settings, under the site permissions section to unlock full site functionality. Click here for help.

Article Image - OPKO Health Acquires EirGen Pharma

Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Scroll to keep reading

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy

You Might Also Like

Holding Property Owners Accountable: The Role of a Premises Liability Attorney

27/11/2023Holding Property Owners Accountable: The Role of a Premises Liability Attorney

Accidents can occur anywhere, often due to property owner negligence. Seeking justice after an injury on private property can be challenging. Experienced Oklahoma City Personal injury attorneys comprehends property owners’ safety obligations. They excel

AI Content Conundrum: Sentiment Degradation Exacerbating the Misinformation Age

13/05/2024AI Content Conundrum: Sentiment Degradation Exacerbating the Misinformation Age

With industries across the board becoming increasingly adept at using AI-driven Large Language Models (LLMs) like OpenAI’s ChatGPT, Anthropic’s Claude2 and Meta AI’s Llama2, it begs one obvious question: How do we make sure all of the content out there i

The Virtuosos of Cloud Consulting

04/11/2019The Virtuosos of Cloud Consulting

At Denny Cherry and Associates Consulting [DCAC], expertise is the primary differentiator from other cloud consulting companies.

Committed to a Culture of Continuous Improvement

01/05/2018Committed to a Culture of Continuous Improvement

Zephus Limited is the wholly-owned subsidiary of Bureau van Dijk that specialises in data collection and research.

Can Automation Help to Eradicate Human Error in the Workplace?

27/09/2022Can Automation Help to Eradicate Human Error in the Workplace?

Each day, businesses across the country handle countless transactions and obtain vast amounts of data. Unfortunately, while processing and utilizing this data, the opportunity for human error is high. These mistakes can be costly.

A Smooth Transition

26/07/2022A Smooth Transition

FP Transitions is a specialized business consulting firm dedicated to wealth managers and independent financial advisors with over twenty years of industry expertise.

Perspective – Four New Firms Acquired

01/12/2023Perspective – Four New Firms Acquired

Perspective Financial Group Acquires Four New Firms with More Growth Set to Come Perspective Financial Group has purchased an additional four financial advisory firms, taking the group’s total to 12 acquisitions in 2023. The four acquisitions are: Bright

LinkedIn Outbound Sales Tactics

08/04/2024LinkedIn Outbound Sales Tactics

The battle for the customer is never-ending. If your company used to be inbound-only but could use some help, appending outbound sales tactics will infuse fresh ideas into your strategy. With the slight difference in who initiates the sales process (whe

Do it yourself: How self-service checkouts are saving companies cash

01/02/2019Do it yourself: How self-service checkouts are saving companies cash

Advancements in technology have had an effect on the way we do our shopping on the high street, as we constantly look to find ways of making the experience as smooth as possible. With no sign of developments slowing down in the world of retail — we investiga

View More Articles

Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

MORE BRANDS